Link Between Plasma Citrulline and Lipopolysaccharide Concentrations in the Critically Ill
- Conditions
- Critically Ill
- Registration Number
- NCT02902276
- Lead Sponsor
- Centre Hospitalier Universitaire de Besancon
- Brief Summary
In critically ill patients, the small bowel permeability is increased, leading to bacterial translocation, and systemic inflammatory response syndrome.
Plasma citrulline is a validated biomarker of functional enterocyte mass. Lipopolysaccharide (LPS) is a part of Gram negative bacteria, and plasma LPS concentration is a biomarker of bacterial translocation. The link between plasma citrulline and LPS in the critically ill is unknown. Investigators hypothesize that patients presenting with low plasma citrulline concentration, with presumed altered small bowel function, would have an increased phenomenon of bacterial translocation, and increased plasma LPS concentration. Investigators aimed to evaluate the link between plasma citrulline and LPS concentrations in critically ill patients at the time of ICU admission.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 120
- Critically ill patients requiring ICU admission for at least 48 hours
- Adults
- Chronic small bowel disease
- Chronic renal failure (clearance of creatinine < 50 mL/min)
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma citrulline concentration Up to 12 hours after admission in the unit biological assay
plasma lipopolysaccharide concentration Up to 12 hours after admission in the unit biological assay
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Centre Hospitalier Universitaire de Besançon
🇫🇷Besançon, France